Goldman Sachs
PALI icon

Goldman Sachs’s Palisade Bio PALI Stock Holding History

Goldman Sachs’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.4M Buy
5,373,951
+4,816,386
+864% +$8.76M ﹤0.01% 3124
2025
Q4 		$1.31M Buy
+557,565
New +$1.07M ﹤0.01% 4923
2017
Q1 		– Hold
0
– -$3K – 6936
2016
Q4 		– Hold
0
– – – 6835
2016
Q3 		– Hold
0
– – – 6936
2016
Q2 		– Hold
0
– – – 6944
2016
Q1 		– Hold
0
– – – 6897
2015
Q4 		– Hold
0
– – – 5849
2015
Q3 		– Sell
-1
Closed -$1.84M – 5329
2015
Q2 		$1.43M Buy
+1
New +$2.18M ﹤0.01% 4189
2015
Q1 		– Hold
0
– – – 6907
2014
Q4 		– Hold
0
– – – 6814
2014
Q3 		– Hold
0
– – – 5303
2014
Q2 		– Hold
0
– – – 4810
2014
Q1 		– Hold
0
– – – 5325

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Goldman Sachs's PALI Position: Q1 2026 in Review

Goldman Sachs increased its Palisade Bio (PALI) stake by 864% in Q1 2026, buying an estimated $8.76M and bringing the position to 5,373,951 shares worth $9.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3124.

Goldman Sachs first reported a position in PALI in Q2 2015 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Goldman Sachs held 5,373,951 shares of Palisade Bio worth $9.4M as of Q1 2026.
  • Goldman Sachs bought 4,816,386 Palisade Bio shares in Q1 2026, an estimated $8.76M.
  • Palisade Bio made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3124 holding.
  • Goldman Sachs first reported a position in Palisade Bio in Q2 2015 and has held it in 3 quarters since.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.